NASDAQ:CLXT
Delisted

Calyxt Stock News

etoro logo Buy CLXT
*Your capital is at risk
$6.30
+0 (+0%)
At Close: Aug 30, 2023

Should You Buy Calyxt (CLXT) Ahead of Earnings?

12:08pm, Wednesday, 03'rd Mar 2021
Calyxt (CLXT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ROSEVILLE, MN / ACCESSWIRE / March 3, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor conferences during the month of March 2021: Bank
World-Renowned Plant-Biochemistry Experts Named to Calyxt's Scientific Advisory Board Chaired by Company Co-Founder Dan Voytas, Ph.D. New Strategic Initiative to Identify High Value Plant-Derived Prod
Calyxt sells a premium soybean cooking oil Calyno   TALEN gene-editing technology is a game-changer   Strong management team with proven track record   What Calyxt does:  Calyxt Inc (NASDAQ:CLX
Calyxt Inc (NASDAQ:CLXT) shares jumped Tuesday after an analyst at Canaccord Genuity Capital markets doubled the firm's price target for the company from $8 to $16 and reiterated a "Buy" rating in a n
Does Calyxt (CLXT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Moving Average Crossover Alert: Calyxt (CLXT)

06:49am, Tuesday, 02'nd Feb 2021
Calyxt (CLXT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

5 High-Flying Stocks Set to Move Higher

05:17pm, Friday, 29'th Jan 2021
These 5 stocks have good reason for further upside.
Does Calyxt (CLXT) have what it takes to be a top stock pick for momentum investors? Let's find out.

7 CRISPR Stocks for the Future of Medicine

06:12pm, Friday, 15'th Jan 2021
Between these seven genetic editing pioneers, you have the widest exposure to the biggest scientific breakthrough of the century. The post 7 CRISPR Stocks for the Future of Medicine appeared first on
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has contracted to sell all 2020 grain production of its high oleic soybean to
Project delays and slower than anticipated growth contradicts CLXT's business model that claim a speedy development cycle using novel gene-editing technologies.
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene's cloud-ba
Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2020 Results - Earnings Call Transcript
ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has agreed to commercial terms with S&W Seed Company (Nasdaq: SANW), a global
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE